|
|
| Research article summary (published 30 Oct 2009): |
The impacts of ERCC1 gene exon VIII alternative splicing on cisplatin-resistance in ovarian cancer cells.
Full Abstract
Excision repair cross complementation group-1 (ERCC1) was reported to be responsible for drug resistance during cancer treatment. In this report, we first proved the existence of ERCC1 exon VIII alternative splicing in ovarian cancer cells. Further investigation showed that over-expressed exon VIII deficient ERCC1 variant failed to change the protein level of ERCC1 in cancer cells, but decreased the excision repair function of ERCC1 and enhanced sensitivity of cancer cells to cisplatin in a dose-dependent manner. The results indicate that ERCC1 exon VIII alternative splicing does exist in some ovarian cancer cell lines, and regulates cisplatin-resistance in ovarian cancer cells.
Author information
Author/s: Sun, Yehong (Y); Li, Tiyuan (T); Ma, Kewei (K); Tian, Zhongkai (Z); Zhu, Ying (Y); Chen, Fuqiang (F); Hu, Gang (G);
Affiliation: Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, PR China.
Journal and publication information
Publication Type: Journal Article
Journal: Cancer investigation (Cancer Invest), published in England. (Language: eng)
Reference: 2009-Nov; vol 27 (issue 9) : pp 891-7
Dates: Created 2009/10/16; Completed 2009/10/29;
PMID: 19832035, status: MEDLINE (last retrieval date: 10/29/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines]
29 Apr 2006 - Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.
29 Jun 2007 - MZF1 possesses a repressively regulatory function in ERCC1 expression.
17 Jan 2006 - Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer.
19 Nov 2006 - Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.
Mar 2006 - Silencing of endo-exonuclease expression sensitizes mouse B16F10 melanoma cells to DNA damaging agents.
9 May 2007 - Applications of genomics in NSCLC.
29 Nov 2005 - ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.
29 Jun 2007 - Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification.
27 Nov 1996 - Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer.
22 Oct 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.